Benzimidazole compounds

Details Benzimidazole compounds Benzimidazole compounds

2007-07-17

2007-07-17

Habte, Kahsay (Department: 1624)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C544S139000, C544S333000, C544S370000, C544S264000, C548S307400, C548S309700, C548S310400, C548S306100, C548S310700, C548S305400, C546S193000

Reexamination Certificate

active

10071978

ABSTRACT:
The present invention is directed to novel benzimidazoles according to representative structures I and II, and their derivatives that possess antibacterial activity. This invention is also directed to compositions including the benzimidazole derivatives, and methods for using the same.

REFERENCES:
patent: 3864490 (1975-02-01), Daum et al.
patent: 888032 (1953-08-01), None
patent: 19916460 (2000-10-01), None
patent: 1354554 (1974-05-01), None
patent: WO00/56712 (2000-09-01), None
patent: WO 01/00615 (2001-01-01), None
patent: WO 01/70705 (2001-09-01), None
Ogura et al. (Journal of Medicinal Chemistry, 1972, vol. 15, No. 9, pp. 923-926).
Vlaovic et al. (Bioscience, Biotechnology, and Biochemistry, 1992, 56(2), 199-206).
Chernova et al. {Khimiko-Farmasevticheski Zhurnai (1991), 25(1), pp. 50-52}.
Hofstadler, S.A. et al., “Mass spectrometry as a drug discovery platform against RNA targets”,Curr. Opin. Drug iscovery Dev., 2000, 3, 423-431.
Hofstadler, S.A. et al., “Analysis of Noncovalent Complexes of DNA and RNA by Mass Spectrometry”,Chem. Rev.(Washington, D.C.) 2001, 101, 377-390.
Griffey, R.H. et al., “Targeted Site-Specific Gas-Phase Cleavage of Oligoribonucleotides. Application in Mass Spectrometry-Based Identification of Ligand Binding Sites”,J. Am. Chem. Soc., 1999, 121, 474-475.
Sannes-Lowery, K.A. et al., “Measuring Dissociation Constants of RNA and Aminoglycoside Antibiotics by Electrospray Ionization Mass Spectrometry”,Analytical Biochemistry, 2000, 280, 264-271.
Griffey, R.H. et al., “Characterization of Low-Affinity Complezes between RNA and Small Molecules Using Electrospray Ionization Mass Spectrometry”,J. Am. Chem. Soc., 2000, 122(41), 9933-9938.
Griffey, R.H. et al., “Determinants of aminoglycoside-binding specificity for rRNA by using mass spectrometry”,Proc. Natl. Acad. Sci. USA, Aug. 1999, 96, 10129-10133.
International Search Report dated Dec. 1, 2004 for International Application No. PCT/US03/38417.
International Search Report dated Jul. 28, 2004 for International Application No. PCT/US03/38093.
Freter et al., Database Caplus on STN(Columbus, OH, USA), No. 98:160710, “Substituted n-(4-idolylpiperidinoalkyl) benzimidazolones and their use as pharmaceutical preparations,” 1983, abstract, EP 58975, see RN 84461-75-6.
Fonquerna et al., Database Capluse on STN (Columbus, OH, USA), No. 136:369609, “Preparation of indolylpiperidines as antihistaminic and antiallergic agents,” 2002, WO 2002-036589, see RN 423174-70-3 etc.
Edwards, Database Caplus on STN (Columbus, OH, USA), No. 79:18714, “Imidazole derivatives,” 1973, abstract, DE 2259345, see RN 42032-10-0 and 42032-11-1.
Teuber et al., Database Caplus on STN (Columbus, OH, USA), No. 132:93320, “Preparation of aminobenzimidazoles and guanidines as novel potassium channel blocking agents,” 2000, WO 2000-001676, see RN 83750-38-3 etc.
Agai et al., Database Caplus on STN (Columbus, OH, USA), No. 85:78096, “Condensed 1,3,5,-triazepines, III Derivatives of 4,5-dihydro-[1,3,5]triazepino1,2-a benzimidazole,”Tetrahedron1976, vol. 32, No. 7, pp. 839-842, abstract, see RN 60078-74-2 and 60078-75-3 etc.
Ogrua et al., Database Caplus on STN (Columbus, OH, USA), No. 77:160002, “Heterocyclic Compounds 10. Synthesis of some imidazo[1,2-a]benzimidazoles with potent analgetic activities,”Journal of Medicinal Chemistry, 1972, vol. 15, No. 9, pp. 923-926, abstract, see RN 38652-78-7 etc.
Sarett et al., Database Caplus on STN (Columbus, OH, USA), No. 56:79451, “Benzimidazoles carrying thiazolyl, thiadiazolyl, and Isothiazolyl substituents in the 2-position,” 1962, US 3017415, abstract, see RN 91843-61-7.
Merck & Co., Database Caplus on STN (Columbus, OH, USA), No. 62:15351, “Substituted Benzimidazoles,” 1964, GB 866796, abstract, see RN 4048-07-1.
E.R. Squibb and Sons, Inc., Database Caplus on STN (Columbus, OH, USA), No. 82:156304, “Pridyl-1H-Benzimidazolc N-Oxide,” 1975, abstract, US 3864350, see RN 55396-67-3.
Warner Lambert Co., Database Caplus on STN (Columbus, OH, USA), No. 108:131822, “Preparation and testing of antiarteriosclerotic substituted benzimidazol-2-yl-and 3H-imidazo[4,5-b]pyridine-2-ylphenoxyalkanoic acids and their salts and esters,” 1988, US 4714762, abstract, see RN 113561-63-0.
Aventis Pharmaceuticals Products Inc., Database Caplus on STN (Columbus, OH, USA), No. 135:3443381, “Preparation of 1-aroyl-piperidinyl benzamidines as inhibitors of factor Xa or tryptase,” 2001, WO 2001-081310, abstract, see RN 370864-68-9.

Affiliated with

Also associated with

Rating

Benzimidazole compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Benzimidazole compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazole compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3779220